Professional Affiliations
Dr. Vikramraj Jain is affiliated with prestigious professional organizations, contributing to the advancement of rheumatology and clinical immunology
Indian Rheumatology Association
Karnataka Rheumatology Association
Educational Videos
Watch informative videos on Rheumatology and Clinical Immunology
Who is a Rheumatologist?
When to See a Joint & Autoimmune Specialist
Protect Your Joints
The Importance of Early Diagnosis
Academics
Dr. Vikramraj Jain's education and specialized training in medicine and rheumatology
MBBS
Bangalore Medical College, Bengaluru, India (2001-2007)
MD Internal Medicine
Sawai Man Singh Medical College, Jaipur, India (2008-2011)
DM Clinical Immunology
JIPMER, Puducherry (2012-2015)
RhMSUS (Musculoskeletal Ultrasound Certification in Rheumatology)
American College of Rheumatology, USA
Research Experience
Key research contributions in Rheumatology and Clinical Immunology
Indian Council of Medical Research :- Short term studentship
for a period of 2 months during 2005 for the project titled "A clinical study of cases of febrile convulsion coming to Vani Vilas Hospital".
Mehta S, Khandelwal PD, Jain VK, Sihag M. A comparative study of racecadotril and single dose octreotide as an anti-secretory agent in acute infective diarrhoea. J Assoc Physicians India. 2012 Nov;60:12-5.
V.K. Jain, P.T. Antony, C.B. Mithun, B.K. Singh, S. Mehra, J. Usdadiya, V.S. Negi. AB0559 “Hypokalemic paralysis in primary Sjogren syndrome: is it a distinct clinical subset which requires lifelong potassium supplementation rather than immunosuppressants?” Published in abstract book of EULAR 2014 in Annals of Rheumatic diseases. DOI: 10.1136/annrheumdis-2014-eular.1739.
Muralidharan N, Antony PT, Jain VK, Mariaselvam CM, Negi VS. Multidrug resistance 1 (MDR1) 3435C>T gene polymorphism influences the clinical phenotype and methotrexate-induced adverse events in South Indian Tamil rheumatoid arthritis. Eur J Clin Pharmacol. 2015 Aug;71(8):959-65
D P Misra, V K. Jain , V S Negi . Splenectomy increases the subsequent risk of systemic lupus erythematosus: a word of caution. Rheumatol Int Dec 2015 . DOI 10.1007/s00296-015-3406-y
Muralidharan N, Mariaselvam CM, Jain VK, Gulati R, Negi VS. ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis. Pharmacogenomics. 2016; 17(3):241-8.
Jain VK, Negi VS. Inflammatory rheumatic diseases in the elderly. Indian J Rheumatol 2016;11:207-15.
Jain A, Misra DP, Jain VK, Negi VS. Spontaneous pneumomediastinum in dermatomyositis. Indian J Rheumatol. 2017 . doi: 10.4103/0973-3698.199129
Jain A, Misra DP, Ramesh A, Basu D, Jain VK, Negi VS. Tuberculosis mimicking primary systemic vasculitis: not to be missed! Tropical doctor. 2017:49475516687432.
Negi VS, Devaraju P, Misra DP, Jain VK, Usdadiya JB, Antony PT, Gulati R.Mannose-binding lectin (MBL) codon 54 (rs1800450) polymorphism predisposes towards medium vessel vasculitis in patients with systemic lupus erythematosus. Clin Rheumatol. 2017 Apr;36(4):837-843. doi: 10.1007/s10067-017-3539-3.
Misra DP, Chengappa KG, Jain VK, Negi VS. Talonavicular and Naviculocuneiform Joint Involvement in Diffuse Idiopathic Skeletal Hyperostosis. J Clin Rheumatol. 2017 Mar;23(2):119. doi: 10.1097/RHU.0000000000000507.
Muralidharan N, Misra DP, Jain VK, Negi VS. Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis. Clin Rheumatol. 2017 Jun;36(6):1253-1259. doi: 10.1007/s10067-017-3608-7.
Chengappa KG , D P Misra, V K Jain, Vir Negi. Sarcoidosis, Neurotoxoplasmosis & Golimumab Therapy.QJM: monthly journal of the Association of Physicians Dec 2016 ;109(12):817-818 doi: 10.1093/qjmed/hcw197
Jain VK. Leflunomide-induced ILD: A rare and potentially fatal complication. IJRCI. 2017;(5)1:CS3 DOI: 10.15305/ijrci/v5i1/230
Mehra, S., Usdadiya, J.B., Jain, V.K. et al. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study. Rheumatol Int (2018). https://doi.org/10.1007/s00296-018-3995-3
Mariaselvam, Christina; Tamouza, Ryad; Krishnamoorthy, Rajagopal; Charron, Dominique; Misra, Durga; Jain, Vikramraj; Negi, Vir. Association of NKG2D gene variants with susceptibility and severity of Rheumatoid Arthritis. Accepted for publication in Clinical & Experimental Immunology. Manuscript ID: CEI-2016-6164.R1
Panneer Devaraju, Sonal Mehra, Reena Gulati, Paul T. Antony, Vikramraj K. Jain, Durga Prasanna Misra, Vir Singh Negi. The IRF5 rs2004640 (G/T) polymorphism is not a genetic risk factor for systemic lupus erythematosus in population from south India. Indian J Med Res. 2018 Jun; 147(6): 560–566. doi: 10.4103/ijmr.IJMR_2025_16
Jain A, Srinivas BH, Emmanuel D, Jain VK, Parameshwaran S, Negi VS. Renal involvement in primary Sjogren's syndrome: a prospective cohort study. Rheumatol Int. 2018 Aug 23. doi: 10.1007/s00296-018-4118-x.
Jain VK, Hegde K, Panchagnula R. Livedoid vasculopathy with mononeuritis multiplex associated with protein S deficiency mimicking systemic vasculitis. Indian J Rheumatol. 2018 Nov. DOI: 10.4103/injr.injr_97_18
Chapter on “Peripheral Spondyloarthritis” published in Monograph on Spondyloarthritis by Indian College of Physicians 2019.
Chapter on “Burden of Osteoarthritis “ in Handbook of Rheumatic diseases – Osteoarthritis published in 2020.
'Psychological Impact of COVID-19 Pandemic on patients with Rheumatological disorders- A Web based cross-sectional multicentric survey' in Indian Journal of Rheumatology . Indian Journal of rheumatology 2020
Chapter on “Interpretation on common investigations in Rheumatology” in Medicine Update 2021.
Chapter on “Osteoarthritis” in Medicine Update. 2021
Mahendradas P, Jain VK, Thomas S, Kawali A, Sanjay S, Shetty BK. Role of secukinumab in ankylosing spondylitis with tubercular uveitis. Indian J Ophthalmol. 2020 Nov;68(11):2569-2572. doi: 10.4103/ijo.IJO_1081_20.
Shobha V, Chanakya K, Haridas V, Kumar S,Chebbi P, Pinto B, et al . Do all patients with rheumatic Diseases have a higher risk of COVID 19? Initial results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC) Indian Journal of Rheumatology ; 16(2):164-168, 2021.
Patil A, Chanakya K, Shenoy P, Chandrashekara S, Haridas V, Kumar S, Daware M, Janardana R, Pinto B, Subramanian R, Nagaraj S, Singh YP, Singhai S, Jois R, Jain V, Srinivasa C, Dharmanand BG, Dharmapalaiah C, Sangeetha KN, Rao VK, Shobha V. A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases. BMC Rheumatol. 2022 Jun 14;6(1):32. doi: 10.1186/s41927-022-00264-0. PMID: 35698182; PMCID: PMC9192133.
Kodishala C, Shobha V, Chandrashekara S,Kumar S, Haridas V, R Rao VK,et al. Clinical profiling of psoriatic arthritis:an observational cross-sectional study from Karnataka Psoriatic Arthritis Cohort. Indian J Rheumatol. 2021
Jain V, Kumar S. Intermetatarsal bursitis in the foot as the initial manifestation of rheumatoid arthritis. Clin Rheumatol. 2022 Jul;41(7):2255-2256. doi: 10.1007/s10067-022-06123-0.
Patil A, Shobha V, Shenoy P, S C, Kumar S, Daware M, Haridas V, Janardana R, Pinto B, Kodishala C, Ramaswamy S, S N, Jain V, Singh YP, Singhai S, C S, Jois R, Rao VK, Dharmapalaiah C, Kn S, Balebail D. Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort. Lupus. 2023 Feb 2:9612033231155837. doi: 10.1177/09612033231155837. Epub ahead of print. PMID: 36731873; PMCID: PMC9899665.
Presentations at Meetings / Conferences
Highlights of Dr. Vikramraj Jain's invited talks and presentations at national and international conferences
Ultrasound based joint score : a good indicator of disease activity in rheumatoid arthritis
Presented a paper entitled “Sickle cell beta thalassemia associated arthropathy” held at Jipmer scientific society on April 2013.
Clinical & Immunological Profile Of Primary Sjögren Syndrome In South Indian Tamils: A Single Centre Experience”.
Oral presentation at Indian rheumatology national conference - IRACON 2014 , held at Chandigarh , titled “Clinical & Immunological Profile Of Primary Sjögren Syndrome In South Indian Tamils: A Single Centre Experience”.
Effect Of Disease Modifying Antirheumatic Drug (DMARD) Therapy On Immune Response To Trivalent Influenza Vaccine In Rheumatoid Arthritis
Talk on “Treatment of lupus nephritis in 2016” at the South zone IRACON (SZIRACON 2016) held at Kozhikode in Feb 2016.
Rheumatological disorders & pregnancy
Talk on “Rheumatological disorders & pregnancy” at COGE Series VI - a clinical approach - CME organized by dept of Obstetrics & Gynaecology , JIPMER held on 10th April 2016 held at JIPMER.
Extra renal SLE, Extra renal vasculitis & Extra renal scleroderma
Talk on “ Extra renal SLE, Extra renal vasculitis & Extra renal scleroderma” at Nephro-Rheumatology meet held on 12th march 2017.
Karnataka rheumatology association annual conference
Conducted workshop on “Musculoskeletal ultrasound in rheumatology” for radiologists and rheumatologists at Karnataka rheumatology association annual conference held at Belgaum in October 2018.
CMC Vellorein
Conducted workshop on “Musculoskeletal ultrasound in rheumatology” for radiologists and rheumatologists at CMC Vellorein May 2019.
Immunological investigations in autoimmune diseases
Talk on “Immunological investigations in autoimmune diseases” at south zone iracon 2019 held in Chennai in 2019.
Stem cell transplant in Rheumatic diseases
Talk on “ Stem cell transplant in Rheumatic diseases” at IRACON 2019 held at Puducherry.
Conducted Procedural skills workshop
Conducted Procedural skills workshop at IRACON 2019 held at Puducherry.
Comparison of risk factors during first and second wave of COVID-19 in patients with Autoimmune Rheumatic diseases(AIRD)-results from KRACC subset
Oral presentation at 24th Asia Pacific League of Associations for Rheumatology congress - APLAR 2022 , held at Hongkong , titled “ Comparison of risk factors during first and second wave of COVID-19 in patients with Autoimmune Rheumatic diseases(AIRD)-results from KRACC subset”.
Debated on Osteoporosis at Sziracon
Debated on Osteoporosis at Sziracon held at Vishakapatnam in 2022.
Immunomodulation in APS
Talk on “Immunomodulation in APS” at SZIRACON 2023 held Coimbatore.
CAR-T cell therapy in autoimmune diseases
Talk on “CAR-T cell therapy in autoimmune diseases” in IRACON 2023 held at hyderabad
Undergraduate QUIZ
Conducted Undergraduate QUIZ at KRACON 2022 held at Hubli
Postgraduate QUIZ
Conducted Postgraduate quiz at KRACON 2023 held at Gulbarga
Basic musculoskeletal ultrasound course
Conducted Basic musculoskeletal ultrasound course as faculty at AIIMS Bilaspur in 2025
Musculoskeletal Ultrasound Workshop at IRACON 2024
Organized Musculoskeletal Ultrasound Workshop at IRACON 2024 held at Bengaluru
Awards & Recognition
Honors and accolades received by Dr. Vikramraj Jain
INDIAN COUNCIL OF MEDICAL RESEARCH (ICMR)
Short term studentship award (2005) during undergraduate training.
RHEUMAWHIZZ 2013
Winner of national rheumatology quiz competition ‘RHEUMAWHIZZ 2013’ held at SGPGI, Lucknow, India.
Best case presenter
Won the Best case presenter award at World Rheumatology forum held at Gurgaon , New Delhi in March 2019.
IRACON 2023
Winner of Best poster award at Rheumatology national conference - IRACON 2023
Google Reviews
Read what our patients have to say about their experience with Dr. Vikram Jain
Namrata K
"Dr. Vikram Jain is truly exceptional. After suffering from unexplained joint pain for years, he accurately diagnosed my autoimmune condition when several other doctors couldn't. His approach is methodical, patient-centered, and highly effective. The improvement in my quality of life has been remarkable. Highly recommended!"
Sridhar B
"I've been living with rheumatoid arthritis for over a decade, and Dr. Jain is by far the best specialist I've consulted. He takes time to listen, explains treatment options clearly, and has helped me achieve better disease management than I thought possible. His knowledge of the latest treatments is impressive, and his staff is courteous and efficient."
Priya M
"Dr. Vikram Jain is a blessing for my daughter who was diagnosed with juvenile arthritis. His expertise in pediatric rheumatology and gentle, reassuring manner made a difficult diagnosis much easier for our family. He created a tailored treatment plan that has allowed her to return to normal childhood activities. The follow-up care has been excellent, with prompt responses to any concerns."
Frequently Asked Questions
Common questions about rheumatology and immunology
Who is a rheumatologist?
A rheumatologist is a specialist physician who deals with diagnosis and treatment of arthritis and other diseases affecting the immune system, together called as autoimmune rheumatic diseases.
What causes autoimmune rheumatic diseases?
Your body has an immune system that protects you from disease and infection. However, due to various reasons, the immune system can attack the healthy cells of the body, causing what we call autoimmune diseases.
Which parts of the body are affected?
Arthritis mainly affects the joints while other musculoskeletal conditions can affect the muscles, tendons, and ligaments. These diseases can also affect other parts of the body, including eyes, skin, internal organs, and the nervous system.
What are the common diseases treated by rheumatologists?
Rheumatologists see over 100 different types of autoimmune diseases affecting both adults as well as children, of which the following are the most common:
- Inflammatory arthritis – Rheumatoid arthritis, Gout, Psoriatic arthritis , Reactive arthritis, Ankylosing spondylitis
- Systemic autoimmune diseases – Lupus , Scleroderma, Vasculitis, Sjogren’s syndrome , Myositis
- Generalized pain conditions – Fibromyalgia and regional pain conditions affecting low back, neck ,shoulder, hip & foot
- Degenerative joint disorders – Osteoarthritis
- Other diseases affecting immune system – Allergic disorders and Primary immunodeficiency diseases